Continuous Ketone Monitoring in People with Diabetes—Part 2

With over 200,000 hospital admissions each year from diabetic ketoacidosis, new continuous ketone monitoring systems can address a critical care gap. In the second part of our special series, Neil Skolnik explores the value of this new technology and delves into specific case studies.

This special episode is sponsored with support from Abbott.

Presented by:

Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Heath Sciences, Boston, Mass.; Clinical pharmacist and the Clinical Director of Cardiometabolic Services at Well Life Medical in Peabody, MA

References:

Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257–1275 doi.org/10.2337/dci24-0032

Continuous ketone monitoring: Exciting implications for clinical practice. Diabetes Obesity, and Metabolism. 2024; 26 (Suppl. 7): 47-58. doi.org/10.1111/dom.15921

Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology. The Lancet Diabetes & Endocrinology. 2026; 14:82 doi.org/10.1016/S2213-8587(25)00331-6